This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the official electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal Register documents. Each document posted on the site includes a link to the corresponding official PDF file on govinfo.gov. This prototype edition of the daily Federal Register on FederalRegister.gov will remain an unofficial informational resource until the Administrative Committee of the Federal Register (ACFR) issues a regulation granting it official legal status. For complete information about, and access to, our official publications and services, go to About the Federal Register on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable regulatory information on FederalRegister.gov with the objective of establishing the XML-based Federal Register as an ACFR-sanctioned publication in the future. While every effort has been made to ensure that the material on FederalRegister.gov is accurately displayed, consistent with the official SGML-based PDF version on govinfo.gov, those relying on it for legal research should verify their results against an official edition of the Federal Register. Until the ACFR grants it official status, the XML rendition of the daily Federal Register on FederalRegister.gov does not provide legal notice to the public or judicial notice to the courts.
Notice of cancellation of consideration of a proposed action Start Printed Page 31796under Section III-A-1 of the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines).
Notice of a discussion of a proposed action under Section III-A-1 published on May 24, 2010 (75 FR 28811) is withdrawn. The discussion that was to be held at the June 16-17, 2010 meeting of the NIH Recombinant DNA Advisory Committee has been deferred at the request of the principal investigator.Start Further Info
FOR FURTHER INFORMATION CONTACT:
OBA by e-mail at email@example.com, or telephone at 301-496-9838, if you have questions, or require additional information.Start Signature
Dated: May 26, 2010.
Acting Director, Office of Biotechnology Activities, National Institutes of Health.
[FR Doc. 2010-13484 Filed 6-3-10; 8:45 am]
BILLING CODE 4140-01-P